↓ Skip to main content
What is this page? Embed badge

Phenotypic Profiling of DPYD Variations Relevant to 5-Fluorouracil Sensitivity Using Real-time Cellular Analysis and In Vitro Measurement of Enzyme Activity

Overview of attention for article published in Cancer Research, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent
2 patents
guideline
3 clinical guideline sources

Readers on

mendeley
127 Mendeley
So far, Altmetric has seen 4 Guidelines that reference this research output.

Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy

Clinical guideline published by International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on

The International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) promotes education, research, and best practices in therapeutic drug monitoring (TDM) and clinical toxicology (CT). It offers resources, guidelines, and a platform for professionals to enhance their skills and knowledge.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of Pharmacogenetics

Clinical guideline published by French National Network of Pharmacogenetics (RNPGx) on

The French National Network of Pharmacogenetics (RNPGx) focuses on integrating pharmacogenetic testing into clinical practice. It provides evidence-based guidelines for genetic testing, emphasizing the impact of genetic variants on drug efficacy and safety, and offers specific recommendations for various medical conditions.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.